Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Demopulos Gregory A MD, Chairman & CEO. Insider active across 2 companies, notably OMEROS CORP. In total, 7 disclosures have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €23k. Activity tracked since 19 May 2021. The latest transaction was disclosed on 18 February 2026 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Demopulos Gregory A MD
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Demopulos Gregory A MD is Chairman, CEO, and President at OMEROS CORP. He is responsible for the strategic direction of the company, which specializes in developing treatments for rare diseases. His leadership is essential in guiding growth and innovation within OMEROS.